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Abstract 
Transdermal drug delivery using microneedles depends on the rate of drug transport through 
the viable epidermis. Therefore minimizing the distance between the drug loaded surface and 
the microcirculation in the dermis where the drug is absorbed into the body is significant in 
improving drug delivery efficiency. A quantifiable relationship between microneedle design 
parameters and skin diffusion properties is therefore desirable, which is what this study aims 
to achieve. A framework is presented to quantitatively determine the effects of design 
parameters on drug diffusion through skin, where the effects of compressive strain on skin 
due to insertion of microneedle are considered. The model is then used to analyse scenarios 
of practical importance. For all scenarios analysed, predicted steady state flux was found to 
be lower when effect of microneedle strain on diffusion coefficient was accounted for. For 
example simulations results indicated increasing tip radius from 5μm to 20μm flux increased 
from 6.56x10-6 mol/m2/s to 7.02x10-6 mol/m2/s for constant diffusion coefficient. However if 
the effect of strain on diffusion coefficient is considered, the calculated flux increases from 
5.30x10-6 mol/m2/s to a peak value of 5.32x10-6 mol/m2/s (at 10μm) and  decreases to 
5.29x10-6 mol/m2/s. This paper contributes by reporting a framework to relate microneedle 
geometry to permeability with inclusion of the possible effects the microneedle design may 
pose on the diffusion coefficient. 
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Introduction 
Microneedles technology is seen as one of the most promising options for painless and 
minimally invasive drug delivery compared with other options such as electroporation [1], 
ultrasound [2] and use of chemical penetration enhancers such as sodium lauryl sulphate [3]. 
Microneedles have been designed to pierce through the stratum corneum (SC) in order to 
deliver drugs to the viable epidermis (VE) where the drug molecules diffuse more easily into 
the dermis from where they are absorbed into the blood vessels. Studies have shown that 
microneedles increase the skin permeability of molecules such as Insulin and Calcein through 
the skin [4-5] albeit giving little attention to the possibilities of different microneedle designs 
having varying effects on drug delivery efficiency. There have been previous studies that 
considered the effect of microneedle geometry on the permeability [6-9]. For example, 
Davidson et al [9] identified the effect of using different microneedle geometry on the 
permeability of drug in skin. In this study the diffusion coefficient of the drug in the skin was 
assumed to be the same when the microneedles were inserted and removed. However, other 
studies have shown that permeability through soft tissue can be significantly altered when a 
mechanical strain is exerted. In transdermal drug transport the efficiency of drug delivery is 
dependent on the rate at which the drugs diffuse through the skin. Therefore, the change in 
the intrinsic diffusion property of the skin when microneedles are inserted must be given 
careful considerations, particular when the microneedles are inserted for long duration.  
The effect of tissue compression on solute or drug permeability has been shown to be 
important in some studies. These include experiments on articular cartilage [10-13] and 
nucleus pulposus and fibrosus [14-15] to analyse the effect of placing compressive force of 
specimen on the permeation of solutes. In these studies, it was shown that compressive 
straining of tissue will cause the permeability of molecules through it to decrease. Roxhed et 
al [16] had previously carried out simulations that showed that when microneedles are 
inserted high hydrostatic pressures are generated in regions of the skin. To counter this they 
designed ultra-sharp hollow microneedles with side openings. Histological samples showed 
that these hollow microneedles were able to pierce human skin. However, observations from 
staining showed that there was leakage when fluid was injected into the skin through the 
hollow microneedles. The study attempted to locate the holes of hollow microneedles in 
regions where the pressure exerted by the microneedles is thought to be minimal. However, 
Roxhed et al [16] did not quantify the effect of the pressure exerted by the microneedle on the 
permeation of drug through the skin. Furthermore, although designing hollow microneedles 
with the opening on the side might allow for design of ultra sharp microneedles for easier 
insertion, other problems associated with hollow microneedles still remains. Design of solid 
coated and polymer microneedles still persist over hollow microneedles because of their 
structural and storage advantages [17] and the main mode of delivery of such microneedles is 
by diffusion through skin. Therefore it is important to consider the changes in diffusion 
coefficient when such microneedles are left to remain inserted in the skin over the period of 
the medication.  
Considering the above issues, the present study aims to develop a quantitative basis for 
analysing the relationship between the microneedle geometry and the diffusion coefficient of 
the skin. It is envisaged that the developed model will allow the design of the microneedle to 
be optimized for more efficient drug delivery. The contribution of this work is mainly 
theoretical, although most of the concepts which constitute the model and the simulations are 
validated with experimental data. The significance of the study is to provide a framework 
which quantifies the effect of microneedle geometry on drug permeation through skin and 
subsequently concentration in the blood with the inclusion of the possible effect the 
microneedle design may pose on the diffusion coefficient. The model and case studies 
simulated illustrate steps and necessary data which would be required to predict performance 
of microneedle based drug delivery systems. Fentanyl is used as the model drug in the case 
studies as it is a drug which is widely delivered through the transdermal route [18-20]. 
Outline of the Conceptual Model  
Structure and permeability of pierced and intact skin 
For the purpose of our work we define the skin to be made up of two distinct layers: the 
epidermis and the dermis. The epidermis is further divided into two main layers which are the 
SC and the VE in consistent with other studies [21-22]. Different forms of transport 
mechanisms have been suggested to describe transdermal transport such as the brick and 
mortar model [23-28] and the Fick’s diffusion models [29-34, 21]. In this study, we shall 
consider the transport of drug as diffusion through the porous pathway in the VE [35-37]. 
When microneedles are inserted into the skin, regions of the skin are compressed in a manner 
which could alter the diffusion coefficient of the skin relative to its unstrained position [16]. 
This is in accordance with other permeation studies on cartilage tissues that compared 
diffusivity of strained and unstrained tissues. Indeed, for the case of hollow microneedles a 
solution to this problem was proposed by Martanto et al [38]. This involved partial retraction 
of the microneedles to allow delivery of more drugs/fluids to the skin [38, 31]. However the 
limitations of hollow microneedles such as leakage still persist making solid microneedles a 
predominant option. However for solid microneedles, which may need to be applied for a 
long duration, the implications of the microneedle geometry on the drug diffusion should be 
considered carefully. For example, hydrogel microneedles [39-40] are strong enough to 
pierce through the skin when dry and upon insertion they absorb moisture from the skin and 
swell allowing drugs to permeate through them into the skin. This design has an advantage 
over hollow microneedles as they are less brittle and blockage is eliminated because the drug 
diffuses through the needle, rather than pass through the tiny lumen as it does in hollow 
microneedles. These types of microneedle drug delivery system requires the microneedles to 
remain inserted in the skin for longer periods as they are designed to be used, either in 
combination with a transdermal patch or with the drug encapsulated within the structure of 
the microneedles from which the release rate can be controlled by the composition of the 
hydrogel material [39].   
 
Force exerted on the skin by inserted microneedles 
First, the manner in which the skin contracts following insertion of microneedle is analysed 
in the context of this work and a model is then proposed. When microneedles are inserted 
into the skin, each exerts a pressure on the skin as it occupies a volume equivalent to the 
volume of the microneedle. For example, a schematic of the stress distribution in deformed 
skin when two microneedles are inserted is shown in Figure 1. The non grey regions indicate 
the non deformed skin while the grey region show the deformed skin with where the 
microneedles exert compressive force on the skin.    
In this study we consider the skin as a homogeneous layer since the only layer being 
considered is the VE. Although the stress distribution may vary across the skin at distances 
away from the needle the exerted pressure shall be assumed to be distributed evenly over the 
area of the skin under the microneedle array. This is thought to be a valid assumption to make 
here since the skin is a non rigid surface and the microneedles are micron sized objects. 
Therefore, for a tightly packed microneedle array the stress will be evenly distributed around 
the diffusion region. This exerted force on the skin causes a decrease in the pore size in the 
VE. The total decrease in pore size is therefore equal to the total volume of microneedles. 
Strain-dependent change in diffusion coefficient 
For the purpose of this study, the dimensions defined are those of the part of the microneedles 
that is inserted into the viable epidermis. The full design length will not insert due to the 
elastic nature of the skin, presence of tiny wrinkles and hairs as observed in several studies 
[4, 57-59]. The dimensions are chosen based on the geometries that have been fabricated in 
literature and this is consistent with previous studies which looked at modelling MNs for drug 
delivery [6-9]. Drug diffusing through the VE is modelled as diffusion through the porous 
pathway within the tissue [35-36]. The hypothesized pores are assumed to be of equal sizes 
and arranged in parallel in the same direction as the general direction of concentration 
gradient between the solid microneedle surface and the sink that is assumed to exist at the 
epidermal/dermal junction [40-41]. The diffusion coefficient discussed here is assumed to be 
isotropic and since the stress is distributed evenly over the region where diffusion takes place, 
diffusion coefficient is also defined to be isotropic when microneedles are inserted. In other 
words, the diffusion coefficient is strain-dependent; however, it does not vary with directions 
and positions. The permeability of drug through the skin is therefore given as [35-37, 42]   
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Where Dr is the diffusion coefficient of the drug through the water filled pores within the VE; 
ε is the skin porosity, τ is the tortuosity and h is the thickness of the VE. Dr relates both the 
drug and skin properties and is given as 
)(DHDr λ=            (2) 
Where D is the diffusion coefficient of the drug at infinite dilution, H(λ) is a  hindrance 
factor. For λ < 0.4 [43, 37] the hindrance factor is given by [42, 35]:   
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λ is the ratio of the hydrodynamic radius of the drug (rp) and the radius of the hypothesized 
pores (rs) in the VE 
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When microneedles are inserted into the skin, the total volume of the skin under the patch is 
decreased by nVneedle, which is the total volume of n microneedles inserted. The size of the 
pores will therefore be decreased, however it is assumed here that the length of the pores will 
not vary, rather the decreased volume will be as a result of the decrease in the size of the 
hypothesized pores from rs to rsi. 
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Where Vpore and Vporei represents the volume of the pores before and after microneedles have 
been inserted; rs and rsi represent the radius of the pore before and after microneedles have 
been inserted into the skin. Path length of diffusion, x, is defined as:  
hx τ=             (6) 
The subscript i indicates microneedle inserted and h represents the effective skin thickness, np 
is the number of pores in the skin area, and this is obtained from the total area of the pores in 
the skin divided by the area of a single pore.  
           (7) 
A is the area under the microneedle array, ε is porosity, and τ is tortuosity. We can therefore 
relate this decrease in pore size due to microneedle inserted with the diffusion coefficient. 
Where the radius of pores with microneedles inserted given as: 
          (8) 
Where Vpore is the volume of pores in the skin prior to microneedle insertion; Vneedle is the 
volume of each microneedle, n is the number of microneedles in the array. This solution for 
rsi can then be substituted into equation 2 to find λ giving the diffusion coefficient with 
microneedle inserted as 
         (9) 
Using this model the geometry of microneedle can thus be related to drug permeability in the 
skin (equations 1 and 9). It can be noted that where microneedles are not used n becomes zero 
(n = 0) and equation (9) gives the diffusion coefficient for skin without microneedle inserted 
based on the porous pathway theory. The values for the necessary parameters used in this 
study are listed in Table 1. Skin thickness varies in different parts of the skin [44] the value 
used here is the skin thickness in the arm which is a practical region for placing a 
microneedle array. 
Drug transport behaviour 
The presented model will be analysed using 3D simulations to obtain the effective skin 
thickness and steady state diffusive flux followed by simulations to predict blood 
concentration profile. Two separate cases will be considered; with the effect of microneedle 
strain on skin accounted for and where the effect of the microneedle strain is ignored.  
Drug permeation in skin  
The 3-D simulations for drug transport in skin are carried out using COMSOL® (COMSOL 
3.0, Multiphysics Software from Comsol, 2005) is simulation software with an easy to use 
practical interface that is able to solve problems in all dimensions using the finite element 
method. Using COMSOL the model structure can be drawn using the built in model builder 
and the properties of each region defined with necessary boundary conditions imposed as 
required. In this particular study, a microneedle inserted into a given area of skin is modelled 
as a tapered structure inserted in a block. The boundary conditions are then defined such that 
the base of the block serves as a sink and the sides of the block are insulated against diffusion 
(i.e. zero flux). The concentration is defined on the surface of the microneedle as constant 
throughout the process and the sub domain settings are used to define the diffusion properties 
of Fentanyl in the skin and microneedles. The problem is then solved to obtain flux values at 
the base of the skin for the different geometries considered.  
 
Diffusion through the SC is eliminated by the use of microneedles; therefore the diffusion 
coefficient that is relevant in this case is that of the VE. We model the steady state diffusion 
of drugs from the surface of the microneedles into the skin [45-46] from Fick’s diffusion 
model [34, 16]: 
Parameters obtained from the developed model (i.e. εDr and x) are implemented in 
COMSOL® in order to fit the porous pathway model into the Fick’s law. The concentration at 
the base is defined as 0 assuming 100% absorption in the dermis (i.e. all drug reaching the 
dermis is immediately absorbed into the blood vessels).  Therefore a sink condition exists in 
this region. Similar assumptions have been used in other studies on transdermal drug delivery 
[47, 34, 16]. The following boundary conditions are implemented in all simulations:  
The initial drug concentration at time t=0 in skin is 0  
 0C =  at Lx0 ≤≤   for  0t =                  (10) 
The concentration of drug on the skin surface Cs, remains constant throughout the duration of 
application since the concentration of Fentanyl in the formulation is very high.  
sCC =  at  Lx0 ≤≤  for 0t >                  (11) 
Assuming 100% absorption, that is, as drug diffuses through the epidermis it is immediately 
absorbed into the microcirculation in the dermis; therefore, at the epidermal/dermal junction 
(at the base of the block/skin model) the concentration remains constant as 0.  
0C =  at hx =  for 0t >                   (12) 
 At steady state the time variation is eliminated such that dC/dt =0. The steady state diffusive 
flux is calculated by rearranging the Fick’s first law  for steady state diffusion [47, 34, 16].  
dx
dCDJss −=                      (13) 
Where Jss is the steady state flux of Fentanyl across skin, D is the diffusion coefficient, C is 
the concentration of Fentanyl and dC/dx is the concentration gradient. The following applies 
at steady state; 
dx
dC =constant = 
eff
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h
CC −                            (14) 
Where Cs is drug concentration on the surface of microneedles, C0 is the concentration at the 
epidermal/dermal junction.  
 
By combining equation (13) with equation (14), and given that C0=0, we obtain the following 
equation for steady state diffusive flux Jss: 
eff
s
ss h
DCJ =                                                    (15) 
 Effective skin thickness is then calculated by rearranging equation (20) for heff. 
Drug concentration in blood  
When the drug on the microneedle diffuses into the skin, it is absorbed into the 
microcirculation after which it is eliminated from the body. The blood concentration profile 
of a drug after microneedle delivery is predicted using SKIN-CAD. The software combines 
both the physicochemical parameters for diffusion of the drug through the skin and 
pharmacokinetics of the drug in the blood to simulate the drug distribution profile in the body 
using the finite difference method. Various models have been proposed to model the 
pharmacokinetics of different drugs absorption and elimination in the body and these have 
been reviewed by Hacker et al [48], here a one compartment model is adopted as it has been 
shown to be applicable to transdermal drug delivery since this mode of delivery bypasses 
absorption in the stomach and intestine. The one compartment model which was developed 
by (equation 16) has also been validated against experimental results to be a good 
approximation for predicting drug concentration in blood following transdermal delivery of 
Fentanyl [49]. In another study, concentration profiles following transdermal delivery of 
Fentanyl using a conventional patch was obtained from various patients and was shown the 
match simulations carried out in SKIN-CAD [19].  
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Vd is the volume of distribution in the blood, Cb is the concentration of the drug in the blood 
at time t, ke is the elimination rate constant, dQ/dt is the rate of skin penetration, An is the 
area of the drug releasing surface of the delivery system, which is calculated as the surface 
area of the microneedles in contact with the VE. 
Results and Discussions 
Comparing modelling with experimental results 
Here we compare diffusion coefficient values determined from the proposed framework with 
experiment carried out on bovine annulus fibrosus (AF) given that there seems to be no 
experiments on diffusion under compression for the VE. In the absence of such experimental 
studies on skin, experiment on bovine AF will suffice for the purpose of validating the 
developed framework in this paper since for both tissues, drug transport can be modelled as 
diffusion through porous pathway and compression will result in decreased pore size. Jackson 
et al [16] studied the effect of strain level on the diffusion coefficient of glucose through 
bovine AF. Results for 0%, 10% and 20% strain showed a decrease in diffusion coefficient as 
strain level increased. The strain is the ratio of change in volume due to compression to the 
initial volume of tissue before deformation. In this case it is expressed as the volume of MN 
inserted to the volume of skin under the array expressed in percentage. To compare these 
results with the model proposed in this study, microneedle geometries were determined to 
exert similar strains on the skin. The strain is calculated from equation (17) where Vneedle is 
the volume of the MN penetrating the VE and Vskin is the volume of skin under the MN array. 
Using equation (17), it was found that geometry with base radius, tip radius and length of 
110μm, 10μm and 130μm, respectively, caused a 10% strain and likewise 110μm, 75μm and 
130μm caused a 20% strain for a 1x10-7μm2 array containing 100 microneedles. 
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Where 
AhVskin =                                            (18) 
Hydrodynamic radius and diffusion coefficient (in interstitial fluid) of glucose was taken to 
be 3.8x10-10m [49] and 1.63 x 10-10m2/s [50], respectively. The model and experiment both 
show lower diffusion coefficient at higher strain level as shown in Figure 2 with comparable 
values of diffusion coefficient. The diffusion coefficient of a particular drug molecule in 
tissue depends on the tortuosity and porosity and pore size and these varies for different 
tissues. Assuming the porosity of AF would be higher than that of skin, porosity and 
tortuosity are estimated to be 0.1 and 2 respectively using the relatively high values reported 
in literature [37] in order to obtain a close comparison.  The differences between the 
experimental and model values are attributable to the estimated tortuosity and porosity used 
in the predictions. Nonetheless, the experiment is useful in validating the model which 
suggests that the diffusion coefficient for such deformable tissue (AF or skin) should drop as 
strain is increased.  Further experiments which demonstrate the concept of strain having an 
effect on the permeation of substances through tissue such as nucleus fibrosus, muscle and 
cartilage tissue has been presented in several texts [52-54, 11-13]. 
Transdermal drug delivery using a microneedle inserted in the skin is modelled in 3-D using 
the method described in preceding section. Table 1 show the parameters used in this study for 
varying the needle geometry for a tapered needle.  
Effect of geometry of microneedle array design on diffusive flux  
To further determine  the significance of the effect of the compressive force exerted by the 
needle on the diffusivity of the drug in the skin the diffusive flux and peak drug concentration 
in blood are obtained for different microneedle geometries. The two cases considered are:  1) 
the diffusion coefficient calculated using equation (10), 2) diffusion coefficient remaining 
constant despite inserted microneedles. Diffusive flux at the epidermal/dermal junction was 
obtained for different microneedle geometries by varying the length of microneedle (L), the 
tip radius (r) and base radius (R). In order to carry out the simulations for a plane drug with 
no pores, the diffusion path length based on the porous pathway model was converted to the 
diffusion path length for a non porous drug by multiplying the turtuorsity by the thickness of 
the skin (equation 6). For all simulations, except were the listed parameter is being varied, the 
dimensions used are L=150μm, R = 80μm, r = 5μm and n =25.  
 
It is expected that if the size of microneedles are increased, this will allow more surface for 
drug loading for solid microneedles. This expected pattern is seen when the diffusion 
coefficient is assumed to be independent of the inserted microneedles as the simulation 
results from previous studies indicated [9, 55]. However, the theory available suggests that 
this might not be the case when the compressive force exerted by the microneedle is 
accounted for as discussed in the preceding sections. This is shown in Figures 3-6 where the 
diffusive flux at the skin/blood interface for both the above cases are compared. These results 
have taken account of both the diffusion pattern and the force exerted on the skin when the 
microneedle is inserted by using 3D simulations in combination with the framework 
presented in this study to determine the diffusion coefficient with microneedles inserted. 
From the results shown in Figures 3-6, it is evident that the flux is higher for the case where 
diffusion coefficient is assumed to be constant. In Figures 4 and 5, increasing the tip and base 
radius decreased the flux when the effect of compression was accounted for using the 
presented model. However results shown in Figure 3 suggest that increasing the length of the 
microneedle has less effect on the diffusion coefficient of the drug such that the advantage of 
decreasing the path length by increasing the penetration depth manifests as an increase in 
flux. The results in Figure 6 show the effect of increasing number of microneedles on drug 
flux through skin, is in accordance with the results from experiments done by Yan et al [56]. 
In the said study it was shown that when the density of microneedles in an array is increased, 
the flux of acyclovir through human cadaver epidermis decreases. It was also shown that 
increasing the length of the microneedles resulted in increased flux however further results 
from the same study [56] showed that this is not always the case.  The results The simulations 
carried out here indicates that this pattern observed in the experimental results may be 
explained by the proposed theory which suggest permeability to be an interplay between 
decreased  skin thickness and increased strain on skin leading to decreased diffusion 
coefficient. This indicates a threshold beyond which increasing the size of microneedles will 
result in decreased permeability of the skin due to decreased diffusion coefficient. Figures 3-6 
are presented with two vertical axes in order to show the change in flux for the two cases 
considered, the significance of these differences depends on the level of precision required 
for individual cases. 
Effect of geometry of microneedles on concentration profiles 
To elucidate the significance of the compressive force further, the next step was to predict the 
blood concentration profiles after the microneedle has been inserted into skin for 4 hours. For 
this purpose we use a model drug, Fentanyl with properties listed in Table 1. Two cases 
considered are again, i.e., 1) the diffusion coefficient calculated using equation (10), 2) 
diffusion coefficient remaining constant despite inserted microneedles. The total surface area 
of the microneedles was calculated and represented as the surface area of transdermal drug 
delivery device for the stripped skin scenario. The results indicate a decrease in peak blood 
concentration when the compressive force of the needle is taken into account, compared to 
when the diffusion coefficient is assumed to be constant despite needle insertion. Blood 
concentration, for example, decreases from 0.00261ng/ml to 0.00239ng/ml when 
microneedles base radius was decreased from 95µm to 85µm this is shown in Figure 7. The 
predicted peak drug concentration in blood also increases as the tip radius and the penetration 
length were increased as shown in Figures 8 and 9. This implies that the effect of the force 
exerted by the inserted microneedles on the diffusion coefficient is significant enough to 
indicate a lower value for the predicted concentration of the drug in the blood. Although 
increasing the size and number of microneedles in an array decreases the average path length 
of diffusion, it may still cause a drop in the diffusion coefficient to an extent where the 
advantage of increasing the size and density of microneedles may become obsolete. This is 
evident in the results displayed in Figure 10. Increasing the number of microneedles 
increased the peak concentration of the drug in the blood, however increasing the number of 
microneedles beyond 75 resulted in a decreased peak concentration.  
The case studies that have been simulated here illustrate how varying the design of 
microneedle structures can be used to vary the delivery rate for microneedle mediated drug 
delivery. This harnesses the advantage of microneedles to deliver drug in precise amount. 
This study presents a framework to use the design of microneedles for controlled drug 
delivery while taking into account the change in the diffusion coefficient due to the strain 
exerted on the skin.  
Conclusion 
This study presents a quantitative method for relating the geometry of microneedles to 
permeability of drug through the skin for the purpose of improving controlled release of drug 
from microneedle based drug delivery systems. The presented model takes into consideration 
possible change in diffusion coefficient of the skin due to insertion of microneedle and the 
significant of accounting for the change in diffusion coefficient due to strain exerted on the 
skin is illustrated in the presented case studies based on mathematical simulations to show 
predictions of drug concentration profiles in the skin and blood. Results obtained indicate that 
increasing the size and density of microneedles in an array would increase the compressive 
force exerted by the microneedles on the skin and this leads to decreased drug permeability. 
Future works could be directed at obtaining experimental data for specific cases and fitting 
into the model for optimization of microneedle design prior to fabrication. Such studies are 
essential in the clinical and commercial development of MNs for drug delivery. 
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Table 1 Values of parameters used in this study except where stated otherwise. Values used 
are similar to those of Fentanyl.  
 
 
Parameter Value 
Porosity of VE, ε  
Tortuosity, τ 
0.00002 (Kushner et al, 2007) 
2.5 (Kushner et al, 2007) 
Thickness of VE, h (m) 0.00018 (Hwang et al, 2002) 
Radius of VE pore, rs (m) 0.00000088 (Kushner et al, 2007) 
Hydrodynamic radius, rp (m) 0.00000026 (Tezel et al, 2002) 
Diffusion coefficient at infinite dilution, D (m2/s) 9.75 x 10-6 (Peck et al, 1996) 
Volume of distribution, Vb (ml) 731000 (Tojo, 2005) 
Elimination rate constant, ke (s-1) 0.0000284 (Tojo, 2005) 
Concentration of drug on skin surface, Cs  
(μg/ml) 
15800 (Tojo, 2005) 
 










